Cargando…

Type 1 neurodegeneration with brain iron accumulation: a case report

BACKGROUND: Type 1 neurodegeneration with brain iron accumulation is a rare neurological disorder with estimated prevalence of one to two per million persons worldwide, characterized by progressive degeneration of basal ganglia, globus pallidus, and reticular part of substantia nigra, produced by br...

Descripción completa

Detalles Bibliográficos
Autores principales: Labrada-Aguilera, Pedro Enrique, Guach-Hevia, David Armando, Almira-Gómez, Carlos Rafael, González-Lago, Daniel Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164527/
https://www.ncbi.nlm.nih.gov/pubmed/35655240
http://dx.doi.org/10.1186/s13256-022-03430-7
_version_ 1784720154551123968
author Labrada-Aguilera, Pedro Enrique
Guach-Hevia, David Armando
Almira-Gómez, Carlos Rafael
González-Lago, Daniel Alejandro
author_facet Labrada-Aguilera, Pedro Enrique
Guach-Hevia, David Armando
Almira-Gómez, Carlos Rafael
González-Lago, Daniel Alejandro
author_sort Labrada-Aguilera, Pedro Enrique
collection PubMed
description BACKGROUND: Type 1 neurodegeneration with brain iron accumulation is a rare neurological disorder with estimated prevalence of one to two per million persons worldwide, characterized by progressive degeneration of basal ganglia, globus pallidus, and reticular part of substantia nigra, produced by brain iron accumulation due to a defect in the gene producing pantothenate kinase 2. Clinical presentations include dystonia, dysarthria, dysphagia, dementia, severe mental retardation, and severe movement disability at later stages. The characteristic pattern on brain magnetic resonance imaging shows the “eye of the tiger” sign. Treatment in late stages is mainly symptomatic. We report the case of a Cuban boy with high-severity brain iron accumulation, with positive clinical and imaging findings diagnosed in a late stage of the illness. This degree of severity has never been reported in Cuba and is rarely reported worldwide. CASE PRESENTATION: We present the case of a 19-year-old male white Cuban boy who presented to our department with features of spasticity, dystonia, gait difficulty, dysarthria, dysphagia, aggressiveness, and sleep disorders. He was diagnosed with pantothenate kinase-associated neurodegeneration on the basis of clinical findings and typical “eye of the tiger” pattern on brain magnetic resonance imaging. Detailed evaluation was carried out, and symptomatic treatment and physiotherapy were started with trihexyphenidyl, cabergoline, baclofen, and intramuscular botulinum neurotoxin as well as daily home sessions of passive stretching, weight bearing, and muscle massaging. At 3 months reevaluation, the patient showed a great improvement of motor function, with a decrease of dystonic symptoms, although language, cognition, and functional independence showed no improvement. The prognosis of the patient remains reserved. CONCLUSION: The diagnosis can be made based on the presence of clinical and imaging features. The presence of “eye-of-the-tiger” sign on magnetic resonance imaging must be considered a nearly pathognomonic sign of neurodegeneration with brain iron accumulation presence. Treatment after high-severity presentation remains directed toward symptomatic findings. Both dopamine agonists and anticholinergic agents are useful to treat motor symptoms, but there is not yet an effective treatment to stop the underlying degeneration. New therapeutic approaches are needed to counteract late stages of the disease and improve prognosis.
format Online
Article
Text
id pubmed-9164527
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91645272022-06-05 Type 1 neurodegeneration with brain iron accumulation: a case report Labrada-Aguilera, Pedro Enrique Guach-Hevia, David Armando Almira-Gómez, Carlos Rafael González-Lago, Daniel Alejandro J Med Case Rep Case Report BACKGROUND: Type 1 neurodegeneration with brain iron accumulation is a rare neurological disorder with estimated prevalence of one to two per million persons worldwide, characterized by progressive degeneration of basal ganglia, globus pallidus, and reticular part of substantia nigra, produced by brain iron accumulation due to a defect in the gene producing pantothenate kinase 2. Clinical presentations include dystonia, dysarthria, dysphagia, dementia, severe mental retardation, and severe movement disability at later stages. The characteristic pattern on brain magnetic resonance imaging shows the “eye of the tiger” sign. Treatment in late stages is mainly symptomatic. We report the case of a Cuban boy with high-severity brain iron accumulation, with positive clinical and imaging findings diagnosed in a late stage of the illness. This degree of severity has never been reported in Cuba and is rarely reported worldwide. CASE PRESENTATION: We present the case of a 19-year-old male white Cuban boy who presented to our department with features of spasticity, dystonia, gait difficulty, dysarthria, dysphagia, aggressiveness, and sleep disorders. He was diagnosed with pantothenate kinase-associated neurodegeneration on the basis of clinical findings and typical “eye of the tiger” pattern on brain magnetic resonance imaging. Detailed evaluation was carried out, and symptomatic treatment and physiotherapy were started with trihexyphenidyl, cabergoline, baclofen, and intramuscular botulinum neurotoxin as well as daily home sessions of passive stretching, weight bearing, and muscle massaging. At 3 months reevaluation, the patient showed a great improvement of motor function, with a decrease of dystonic symptoms, although language, cognition, and functional independence showed no improvement. The prognosis of the patient remains reserved. CONCLUSION: The diagnosis can be made based on the presence of clinical and imaging features. The presence of “eye-of-the-tiger” sign on magnetic resonance imaging must be considered a nearly pathognomonic sign of neurodegeneration with brain iron accumulation presence. Treatment after high-severity presentation remains directed toward symptomatic findings. Both dopamine agonists and anticholinergic agents are useful to treat motor symptoms, but there is not yet an effective treatment to stop the underlying degeneration. New therapeutic approaches are needed to counteract late stages of the disease and improve prognosis. BioMed Central 2022-06-03 /pmc/articles/PMC9164527/ /pubmed/35655240 http://dx.doi.org/10.1186/s13256-022-03430-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Labrada-Aguilera, Pedro Enrique
Guach-Hevia, David Armando
Almira-Gómez, Carlos Rafael
González-Lago, Daniel Alejandro
Type 1 neurodegeneration with brain iron accumulation: a case report
title Type 1 neurodegeneration with brain iron accumulation: a case report
title_full Type 1 neurodegeneration with brain iron accumulation: a case report
title_fullStr Type 1 neurodegeneration with brain iron accumulation: a case report
title_full_unstemmed Type 1 neurodegeneration with brain iron accumulation: a case report
title_short Type 1 neurodegeneration with brain iron accumulation: a case report
title_sort type 1 neurodegeneration with brain iron accumulation: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164527/
https://www.ncbi.nlm.nih.gov/pubmed/35655240
http://dx.doi.org/10.1186/s13256-022-03430-7
work_keys_str_mv AT labradaaguilerapedroenrique type1neurodegenerationwithbrainironaccumulationacasereport
AT guachheviadavidarmando type1neurodegenerationwithbrainironaccumulationacasereport
AT almiragomezcarlosrafael type1neurodegenerationwithbrainironaccumulationacasereport
AT gonzalezlagodanielalejandro type1neurodegenerationwithbrainironaccumulationacasereport